FindTrial
Sign In

Clinical Study on the Improvement of Sepsis-Associated Acute Kidney Injury by Novel Polyethersulfone Filters

Clinical Study on the Improvement of Sepsis-Associated Acute Kidney Injury by Novel Polyethersulfone Filters

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500108527
Enrollment
Unknown
Registered
2025-09-01
Start date
2025-09-01
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Interventions

HF12:Treatment with the HF12 filter.
AN69:Treatment with the AN69 filter.
ST150+HA380:Treatment with the ST150+HA380 filter.

Sponsors

The Second Affiliated Hospital of Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. The patient is diagnosed with S-AKI (sepsis-associated acute kidney injury) upon admission to the ICU. 2. The patient's age is between 18 and 80 years old. 3. It is expected that CRRT treatment will be used for at least 24 hours. 4. Sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Age 80 years old; 2. Pregnant and lactating patients; 3. The cumulative CRRT time does not exceed 12 hours; 4. Patients with a history of malignant tumors or other advanced diseases.

Design outcomes

Primary

MeasureTime frame
IL-6;IL-1ß;TNF-a;—

Secondary

MeasureTime frame
ICU length of stay;Total length of stay;—

Countries

China

Contacts

Public ContactJiang xuesong

The Second Affiliated Hospital of Harbin Medical University

cedar_1979@163.com+86 189 0450 3376

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026